Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

28
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
28
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

35
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
35
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

543
Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
543
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

82
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
82
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

33
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
33
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

44
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
44

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inducing <i>Oxalobacter formigenes</i> Colonization Reduces Urinary Oxalate in Healthy Adults.

Kidney international reports·2025
Same author

Eligibility of Living Kidney Donors with Kidney Stone Disease.

American journal of nephrology·2025
Same author

Endourology and Nephrolithiasis.

The Journal of urology·2025
Same author

Endourology and Nephrolithiasis.

The Journal of urology·2025
Same author

Endourology and Nephrolithiasis.

The Journal of urology·2025
Same author

Endourology and Nephrolithiasis.

The Journal of urology·2025

Related Experiment Video

Updated: Sep 17, 2025

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

3.7K

Hyperoxaluria: Diagnosis and Treatment.

Owen P Cunneely1, Feres Camargo Maluf2, Sonia Fargue2

  • 1School of Medicine, University of Alabama at Birmingham, FOT 1120 1720 2nd Avenue South, Birmingham, AL 35294-3411, USA.

The Urologic Clinics of North America
|July 3, 2025
PubMed
Summary

Hyperoxaluria, a condition causing kidney stones and kidney failure, has distinct types: primary (genetic), enteric (gut-related), and idiopathic. New RNA drugs help primary hyperoxaluria, while enteric hyperoxaluria needs better treatments.

Keywords:
Enteric hyperoxaluriaHyperoxaluriaKidney stonesOxalatePrimary hyperoxaluriaUrolithiasis

More Related Videos

HPLC Measurement of the DNA Oxidation Biomarker, 8-oxo-7,8-dihydro-2&#8217;-deoxyguanosine, in Cultured Cells and Animal Tissues
14:12

HPLC Measurement of the DNA Oxidation Biomarker, 8-oxo-7,8-dihydro-2’-deoxyguanosine, in Cultured Cells and Animal Tissues

Published on: August 1, 2015

27.3K
Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.2K

Related Experiment Videos

Last Updated: Sep 17, 2025

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

3.7K
HPLC Measurement of the DNA Oxidation Biomarker, 8-oxo-7,8-dihydro-2&#8217;-deoxyguanosine, in Cultured Cells and Animal Tissues
14:12

HPLC Measurement of the DNA Oxidation Biomarker, 8-oxo-7,8-dihydro-2’-deoxyguanosine, in Cultured Cells and Animal Tissues

Published on: August 1, 2015

27.3K
Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.2K

Area of Science:

  • Nephrology
  • Genetics
  • Gastroenterology

Background:

  • Hyperoxaluria encompasses primary (PH), enteric (EH), and idiopathic (IH) forms, potentially leading to end-stage renal disease (ESRD).
  • PH involves genetic oxalate overproduction, whereas EH stems from fat malabsorption and increased intestinal oxalate absorption.
  • Current therapeutic options for EH are limited, highlighting the need for novel interventions targeting intestinal oxalate absorption.

Purpose of the Study:

  • To review the classification and current therapeutic landscape of hyperoxaluria.
  • To highlight advancements in treating primary hyperoxaluria with RNA inhibitory drugs.
  • To underscore the unmet need for effective therapies for enteric hyperoxaluria.

Main Methods:

  • Literature review of hyperoxaluria classification and treatment modalities.
  • Analysis of novel RNA inhibitory drugs for primary hyperoxaluria.
  • Examination of therapeutic strategies for enteric hyperoxaluria.

Main Results:

  • Novel RNA inhibitory drugs have shown significant success in reducing kidney stone risk for primary hyperoxaluria patients.
  • Enteric hyperoxaluria management remains challenging due to limited treatment options.
  • Idiopathic hyperoxaluria etiology is not fully understood, suggesting multifactorial causes.

Conclusions:

  • Primary hyperoxaluria can be effectively managed with new RNA-targeted therapies.
  • Further research is crucial to develop effective treatments for enteric hyperoxaluria.
  • Understanding the diverse mechanisms of hyperoxaluria is key to improving patient outcomes.